AMY BATES: Open Payments
NPI 1609196443 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 74 payments from 18 companies in 2025. Trend: 2023 $592 · 2024 $1,424 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $245 |
| ABBVIE INC. | 13 | $198 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| Novo Nordisk Inc | 8 | $137 |
| PFIZER INC. | 5 | $90 |
| Exact Sciences Corporation | 3 | $63 |
| Astellas Pharma US Inc | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
Products named: MOUNJARO, VRAYLAR, AIRSUPRA, JARDIANCE, ELIQUIS, Cologuard Collection Kit, Veozah, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
